Aldeyra Therapeutics, Inc. - Common Stock (ALDX)
CUSIP: 01438T106
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 59,794,743
- Total 13F shares
- 6,358,443
- Share change
- +1,984,376
- Total reported value
- $36,177,450
- Price per share
- $5.69
- Number of holders
- 25
- Value change
- +$11,374,826
- Number of buys
- 15
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 01438T106?
CUSIP 01438T106 identifies ALDX - Aldeyra Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 01438T106:
Top shareholders of ALDX - Aldeyra Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
2.4%
|
1,437,811
|
$6,024,000 | — | 31 Mar 2016 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
2.1%
|
1,240,458
|
$5,197,000 | — | 31 Mar 2016 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.79%
|
471,259
|
$1,975,000 | — | 31 Mar 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.4%
|
238,500
|
$999,000 | — | 31 Mar 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.29%
|
176,232
|
$738,000 | — | 31 Mar 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.24%
|
142,000
|
$595,000 | — | 31 Mar 2016 | |
| Knoll Capital Management, LLC |
13F
|
Company |
0.23%
|
135,800
|
$569,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.2%
|
121,407
|
$508,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.17%
|
100,045
|
$419,000 | — | 31 Mar 2016 | |
| Weiss Multi-Strategy Advisers LLC |
13F
|
Company |
0.12%
|
71,172
|
$298,000 | — | 31 Mar 2016 | |
| Boxer Capital, LLC |
13F
|
Company |
0.11%
|
63,146
|
$265,000 | — | 31 Mar 2016 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.1%
|
57,500
|
$241,000 | — | 31 Mar 2016 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
41,096
|
$172,000 | — | 31 Mar 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
23,558
|
$98,000 | — | 31 Mar 2016 | |
| CROFT-LEOMINSTER INC |
13F
|
Company |
0.03%
|
17,000
|
$71,000 | — | 31 Mar 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.02%
|
12,286
|
$51,000 | — | 31 Mar 2016 | |
| FNY Managed Accounts LLC |
13F
|
Company |
0.01%
|
6,502
|
$27,243 | — | 31 Mar 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
3,589
|
$15,000 | — | 31 Mar 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
2,978
|
$12,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
2,784
|
$12,000 | — | 31 Mar 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,000
|
$8,000 | — | 31 Mar 2016 | |
| Vantage Investment Advisors, LLC |
13F
|
Company |
0%
|
2,000
|
$8,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
1,009
|
$4,000 | — | 31 Mar 2016 | |
| BlackRock Investment Management, LLC |
13F
|
Company |
0%
|
958
|
$4,000 | — | 31 Mar 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
941
|
$4,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
636
|
$3,000 | — | 31 Mar 2016 | |
| Walleye Trading LLC |
13F
|
Company |
0%
|
300
|
$1,000 | — | 31 Mar 2016 |
Institutional Holders of Aldeyra Therapeutics, Inc. - Common Stock (ALDX) as of Q2 2016
As of 30 Jun 2016,
Aldeyra Therapeutics, Inc. - Common Stock (ALDX) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,358,443 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, FMR LLC, AWM Investment Company, Inc., SPHERA FUNDS MANAGEMENT LTD., Boxer Capital, LLC, DEERFIELD MANAGEMENT CO, BAKER BROS. ADVISORS LP, Knoll Capital Management, LP, MILLENNIUM MANAGEMENT LLC, and VANGUARD GROUP INC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
26
Q2 2016 holders
25
Holder diff
-1
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.